DK3558330T3 - Anvendelse af mælkesyrebakterier til behandling eller forebyggelse af gestionel diabetes mellitus - Google Patents

Anvendelse af mælkesyrebakterier til behandling eller forebyggelse af gestionel diabetes mellitus Download PDF

Info

Publication number
DK3558330T3
DK3558330T3 DK17883875.1T DK17883875T DK3558330T3 DK 3558330 T3 DK3558330 T3 DK 3558330T3 DK 17883875 T DK17883875 T DK 17883875T DK 3558330 T3 DK3558330 T3 DK 3558330T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
lactic acid
acid bacteria
diabetes mellitus
Prior art date
Application number
DK17883875.1T
Other languages
English (en)
Inventor
Kristin Lee Wickens
Original Assignee
Univ Of Otago
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Of Otago filed Critical Univ Of Otago
Application granted granted Critical
Publication of DK3558330T3 publication Critical patent/DK3558330T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Dairy Products (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK17883875.1T 2016-12-22 2017-06-02 Anvendelse af mælkesyrebakterier til behandling eller forebyggelse af gestionel diabetes mellitus DK3558330T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ72791416 2016-12-22
PCT/IB2017/053262 WO2018115985A1 (en) 2016-12-22 2017-06-02 Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus

Publications (1)

Publication Number Publication Date
DK3558330T3 true DK3558330T3 (da) 2022-11-07

Family

ID=62624701

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17883875.1T DK3558330T3 (da) 2016-12-22 2017-06-02 Anvendelse af mælkesyrebakterier til behandling eller forebyggelse af gestionel diabetes mellitus

Country Status (14)

Country Link
US (2) US11395839B2 (da)
EP (1) EP3558330B1 (da)
JP (1) JP7092380B2 (da)
KR (1) KR102513639B1 (da)
CN (1) CN110290795A (da)
AU (1) AU2017380603B2 (da)
CA (1) CA3047920C (da)
DK (1) DK3558330T3 (da)
MX (1) MX2019007555A (da)
MY (1) MY197917A (da)
NZ (1) NZ754706A (da)
PH (1) PH12019501439B1 (da)
RU (1) RU2769312C2 (da)
WO (1) WO2018115985A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3558330T3 (da) * 2016-12-22 2022-11-07 Univ Of Otago Anvendelse af mælkesyrebakterier til behandling eller forebyggelse af gestionel diabetes mellitus
EP4014756A1 (en) * 2020-12-15 2022-06-22 DuPont Nutrition Biosciences ApS Bioprocessing of protein with probiotic bacteria to improve amino acid and peptide availability
AU2021405296A1 (en) * 2020-12-22 2023-07-06 Fonterra Co-Operative Group Limited Use of lactic acid bacteria to inhibit methanogen growth or reduce methane emissions
CN114990004B (zh) * 2022-04-19 2023-09-15 尚品健康科技(青岛)有限公司 一种分泌型免疫球蛋白a包裹态罗伊氏乳杆菌及防治妊娠糖尿病的应用
US20260053902A1 (en) * 2023-01-26 2026-02-26 Wisconsin Alumni Research Foundation Compositions and methods for reducing the rate of type 1 diabetes
CN116694537B (zh) * 2023-07-28 2023-10-31 善恩康生物科技(苏州)有限公司 鼠李糖乳酪杆菌及其在制备治疗2型糖尿病产品中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000122A1 (en) 1996-07-01 1998-01-08 Sepracor, Inc. Methods and compositions for treating urinary incontinence using enantiomerically enriched (s)-tridihexethyl
GB2338245B (en) * 1997-08-21 2001-11-21 New Zealand Dairy Board Immunity enhancing lactic acid bacteria
US20030191193A1 (en) 2002-04-03 2003-10-09 Jillian Cornish Lactoferrin
EP1937298A4 (en) 2005-10-14 2009-11-11 Auckland Uniservices Ltd USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES
AR060029A1 (es) 2006-03-02 2008-05-21 Unistraw Patent Holdings Ltd Pajilla para beber adaptada para acondicionar progresivamente un ingrediente activo y metodo de fabricar dicha pajilla
TW200841847A (en) 2006-11-06 2008-11-01 Unistraw Patent Holdings Ltd Functional filter for drinking straw
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
US20110189149A1 (en) * 2008-06-20 2011-08-04 Remy Burcelin New Uses of Lactic Acid Bacteria and Bifidobacteria
MX2011005527A (es) * 2008-11-28 2011-09-28 Univ Otago Uso de la bacteria de acido lactico para tratar o prevenir el eczema.
NZ601141A (en) * 2010-01-19 2014-07-25 Abbott Lab Nutritional formulas containing synbiotics
MX382895B (es) * 2015-06-11 2025-03-13 Soc Des Produits Nestle S A Star Suplemento dietético.
DK3558330T3 (da) * 2016-12-22 2022-11-07 Univ Of Otago Anvendelse af mælkesyrebakterier til behandling eller forebyggelse af gestionel diabetes mellitus

Also Published As

Publication number Publication date
CN110290795A (zh) 2019-09-27
AU2017380603B2 (en) 2022-02-03
CA3047920A1 (en) 2018-06-28
US20200093873A1 (en) 2020-03-26
BR112019012965A2 (pt) 2019-11-26
US20220387527A1 (en) 2022-12-08
US11395839B2 (en) 2022-07-26
NZ754706A (en) 2022-09-30
AU2017380603A1 (en) 2019-07-11
JP7092380B2 (ja) 2022-06-28
RU2769312C2 (ru) 2022-03-30
PH12019501439A1 (en) 2020-02-24
MY197917A (en) 2023-07-25
CA3047920C (en) 2022-07-19
MX2019007555A (es) 2020-01-30
KR20190107032A (ko) 2019-09-18
WO2018115985A1 (en) 2018-06-28
PH12019501439B1 (en) 2024-02-23
EP3558330A4 (en) 2020-07-08
RU2019122811A (ru) 2021-01-25
EP3558330A1 (en) 2019-10-30
JP2020502247A (ja) 2020-01-23
RU2019122811A3 (da) 2021-01-25
KR102513639B1 (ko) 2023-03-23
US12377125B2 (en) 2025-08-05
EP3558330B1 (en) 2022-09-21

Similar Documents

Publication Publication Date Title
IL258402B1 (en) Electroporation for obesity or diabetes treatment
DK3212208T3 (da) Anvendelse af l. reuteri til forebyggelse eller behandling af mikrobiotadysbiose tidligt i livet
DK3125875T3 (da) Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
EP4005522C0 (en) STRUCTURAL ADJUSTMENT SYSTEMS FOR A REMOTELY CONTROLLED MEDICAL SYSTEM
ME03422B (me) Jedinjenja dihidrobenzofurana korisna u liječenju dijabetesa i gojaznosti
DK3395353T3 (da) Plasminogen til anvendelse til behandling eller forebyggelse af diabetes-mellitus-nerveskade
DK3143025T3 (da) Forbindelser til behandling af spinal muskelatrofi
DK3119397T3 (da) Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
DK3511328T3 (da) Organiske monobactam-forbindelser til behandling af bakterieinfektioner
DK3558330T3 (da) Anvendelse af mælkesyrebakterier til behandling eller forebyggelse af gestionel diabetes mellitus
EP4056208C0 (en) BLOOD PROCESSING SYSTEMS
DK3110840T3 (da) A22k, desb27, b29r, des b30, ved epsilon-position af lysin 22 acyleret human insulinanalog
EP3673899C0 (en) NASAL POWDER FORMULATION FOR THE TREATMENT OF HYPOGLYCEMIA
EP3190886C0 (en) COMPOSITIONS FOR USE IN THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME
DK3236960T3 (da) Fluralaner til anvendelse i behandling af demodicose
EP3177311C0 (en) COMBINATION OF MEDICINAL PRODUCTS CONTAINING CABOZANTINIB AND A PROTEASOME INHIBITOR FOR THE TREATMENT OF MULTIPLE MYELOMA
DK3318251T3 (da) Sammensætning til forebyggelse eller behandling af fedme eller lipidrelateret metabolisk sygdom
DK3220952T3 (da) Fremgangsmåde til behandling eller forebyggelse af slagtilfælde
LT3153511T (lt) 2-acilaminotiazolo dariniai, skirti panaudoti šlapimo pūslės/šlapimo takų ligų prevencijai arba gydymui
LT3113778T (lt) Piridazino dariniai, skirti naudoti ataksinio sutrikimo profilaktikai arba gydymui
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner
DK3506901T3 (da) Anvendelse af kynurensyre til behandling af muskelatrofi
DK3373931T3 (da) Heterocykliske forbindelser til behandling af sygdom
DK3506956T3 (da) Lægemiddel, særlig til behandling af fistler
BR112016029238A2 (pt) método e aparelhos para fornecer uma solução para o tratamento de sangue.